{
  "paper_metadata": {
    "pmid": "38142462",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the BRCA2 R2645G variant, its functional implications, and potential clinical significance in breast cancer."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7934G>A",
      "protein_notation": "p.Arg2645Gly",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, breast cancer patient",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Here, we report that the variant R2645G, identified in breast cancer..."
        }
      ],
      "functional_data": {
        "summary": "The R2645G variant increases ssDNA binding activity and induces a hyper-recombination phenotype.",
        "assays": [
          "gene targeting reporter assay",
          "viability assays in mouse embryonic stem cells",
          "PARP inhibitor sensitivity assays"
        ]
      },
      "segregation_data": "The variant was identified in a breast cancer patient, suggesting potential segregation with disease.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant's effects on DNA binding and recombination suggest a role in cancer predisposition.",
      "key_quotes": [
        "This function is executed in part by its canonical DNA binding domain located at the C-terminus.",
        "Human cells expressing this variant display a hyper-recombination phenotype."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the variant was clearly described in the text."
  }
}